ID   IQGA2_HUMAN             Reviewed;        1575 AA.
AC   Q13576; A8K4V1; B7Z8A4; J3KR91;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 4.
DT   28-JUN-2023, entry version 206.
DE   RecName: Full=Ras GTPase-activating-like protein IQGAP2;
GN   Name=IQGAP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS GLU-527; GLU-532;
RP   PHE-629 AND VAL-724.
RC   TISSUE=Liver;
RX   PubMed=8756646; DOI=10.1128/mcb.16.9.4869;
RA   Brill S., Li S., Lyman C.W., Church D.M., Wasmuth J.J., Weissbach L.,
RA   Bernards A., Snijders A.J.;
RT   "The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a
RT   potential actin binding domain and interacts with calmodulin and Rho family
RT   GTPases.";
RL   Mol. Cell. Biol. 16:4869-4878(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS GLU-527; GLU-532;
RP   PHE-629 AND VAL-724.
RA   Wang H., Huo R., Xu Z.Y., Xu M., Li J.M., Zhou Z.M., Sha J.H.;
RT   "Cloning and characterization of a novel isoform of IQGAP2 in human adult
RT   testis.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANTS
RP   GLU-527 AND GLU-532.
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-13 (ISOFORM 1).
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-595; SER-1358 AND
RP   SER-1461, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; THR-356; SER-599;
RP   SER-685; THR-716; THR-782; THR-1002; THR-1269; SER-1271; SER-1279 AND
RP   SER-1358, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-629, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   VARIANTS CYS-1445 AND ILE-1530.
RX   PubMed=23033978; DOI=10.1056/nejmoa1206524;
RA   de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G.,
RA   Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C.,
RA   del Rosario M., Hoischen A., Scheffer H., de Vries B.B., Brunner H.G.,
RA   Veltman J.A., Vissers L.E.;
RT   "Diagnostic exome sequencing in persons with severe intellectual
RT   disability.";
RL   N. Engl. J. Med. 367:1921-1929(2012).
CC   -!- FUNCTION: Binds to activated CDC42 and RAC1 but does not seem to
CC       stimulate their GTPase activity. Associates with calmodulin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13576-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13576-2; Sequence=VSP_010629, VSP_010630, VSP_010631;
CC       Name=3;
CC         IsoId=Q13576-3; Sequence=VSP_010629, VSP_055149, VSP_010631;
CC   -!- TISSUE SPECIFICITY: Isoform 2 expression is enhanced in testis.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U51903; AAB37765.1; -; mRNA.
DR   EMBL; AY351902; AAQ81291.1; -; mRNA.
DR   EMBL; AK291066; BAF83755.1; -; mRNA.
DR   EMBL; AK303054; BAH13890.1; -; mRNA.
DR   EMBL; AC025188; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026706; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026725; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093251; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112173; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS34188.1; -. [Q13576-1]
DR   CCDS; CCDS68897.1; -. [Q13576-2]
DR   CCDS; CCDS68898.1; -. [Q13576-3]
DR   RefSeq; NP_001272389.1; NM_001285460.1.
DR   RefSeq; NP_001272390.1; NM_001285461.1. [Q13576-2]
DR   RefSeq; NP_001272391.1; NM_001285462.1. [Q13576-3]
DR   RefSeq; NP_006624.2; NM_006633.3. [Q13576-1]
DR   PDB; 3IEZ; X-ray; 1.50 A; A/B=1476-1571.
DR   PDB; 4EZA; X-ray; 1.50 A; A/B=1476-1571.
DR   PDB; 5CJP; X-ray; 2.60 A; E/F=875-1258.
DR   PDBsum; 3IEZ; -.
DR   PDBsum; 4EZA; -.
DR   PDBsum; 5CJP; -.
DR   AlphaFoldDB; Q13576; -.
DR   SMR; Q13576; -.
DR   BioGRID; 116004; 164.
DR   CORUM; Q13576; -.
DR   DIP; DIP-27542N; -.
DR   IntAct; Q13576; 35.
DR   MINT; Q13576; -.
DR   STRING; 9606.ENSP00000274364; -.
DR   CarbonylDB; Q13576; -.
DR   GlyCosmos; Q13576; 1 site, 2 glycans.
DR   GlyGen; Q13576; 4 sites, 2 O-linked glycans (4 sites).
DR   iPTMnet; Q13576; -.
DR   MetOSite; Q13576; -.
DR   PhosphoSitePlus; Q13576; -.
DR   BioMuta; IQGAP2; -.
DR   DMDM; 292495090; -.
DR   OGP; Q13576; -.
DR   EPD; Q13576; -.
DR   jPOST; Q13576; -.
DR   MassIVE; Q13576; -.
DR   MaxQB; Q13576; -.
DR   PaxDb; Q13576; -.
DR   PeptideAtlas; Q13576; -.
DR   ProteomicsDB; 59581; -. [Q13576-1]
DR   ProteomicsDB; 59582; -. [Q13576-2]
DR   Antibodypedia; 3789; 226 antibodies from 33 providers.
DR   DNASU; 10788; -.
DR   Ensembl; ENST00000274364.11; ENSP00000274364.6; ENSG00000145703.17. [Q13576-1]
DR   Ensembl; ENST00000396234.7; ENSP00000379535.3; ENSG00000145703.17. [Q13576-2]
DR   Ensembl; ENST00000502745.5; ENSP00000426027.1; ENSG00000145703.17. [Q13576-3]
DR   GeneID; 10788; -.
DR   KEGG; hsa:10788; -.
DR   MANE-Select; ENST00000274364.11; ENSP00000274364.6; NM_006633.5; NP_006624.3.
DR   UCSC; uc003kek.5; human. [Q13576-1]
DR   AGR; HGNC:6111; -.
DR   CTD; 10788; -.
DR   DisGeNET; 10788; -.
DR   GeneCards; IQGAP2; -.
DR   HGNC; HGNC:6111; IQGAP2.
DR   HPA; ENSG00000145703; Tissue enhanced (liver).
DR   MIM; 605401; gene.
DR   neXtProt; NX_Q13576; -.
DR   OpenTargets; ENSG00000145703; -.
DR   PharmGKB; PA29911; -.
DR   VEuPathDB; HostDB:ENSG00000145703; -.
DR   eggNOG; KOG2128; Eukaryota.
DR   GeneTree; ENSGT00950000183076; -.
DR   HOGENOM; CLU_000972_2_1_1; -.
DR   InParanoid; Q13576; -.
DR   OMA; CANKYYD; -.
DR   OrthoDB; 12619at2759; -.
DR   PhylomeDB; Q13576; -.
DR   TreeFam; TF313078; -.
DR   PathwayCommons; Q13576; -.
DR   Reactome; R-HSA-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013408; RHOG GTPase cycle.
DR   SignaLink; Q13576; -.
DR   BioGRID-ORCS; 10788; 13 hits in 1160 CRISPR screens.
DR   ChiTaRS; IQGAP2; human.
DR   EvolutionaryTrace; Q13576; -.
DR   GeneWiki; IQGAP2; -.
DR   GenomeRNAi; 10788; -.
DR   Pharos; Q13576; Tbio.
DR   PRO; PR:Q13576; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q13576; protein.
DR   Bgee; ENSG00000145703; Expressed in jejunal mucosa and 165 other tissues.
DR   ExpressionAtlas; Q13576; baseline and differential.
DR   Genevisible; Q13576; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0003779; F:actin binding; TAS:ProtInc.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0071933; F:Arp2/3 complex binding; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IPI:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IBA:GO_Central.
DR   GO; GO:0005095; F:GTPase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; IDA:UniProtKB.
DR   GO; GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IDA:UniProtKB.
DR   GO; GO:1903479; P:mitotic actomyosin contractile ring assembly actin filament organization; IBA:GO_Central.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0070493; P:thrombin-activated receptor signaling pathway; IDA:UniProtKB.
DR   CDD; cd21275; CH_IQGAP2; 1.
DR   Gene3D; 1.20.5.190; -; 1.
DR   Gene3D; 1.10.418.10; Calponin-like domain; 1.
DR   InterPro; IPR001715; CH_dom.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR000593; RasGAP_C.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR001202; WW_dom.
DR   PANTHER; PTHR14149; RAS GTPASE-ACTIVATING PROTEIN WITH IQ MOTIF; 1.
DR   PANTHER; PTHR14149:SF12; RAS GTPASE-ACTIVATING-LIKE PROTEIN IQGAP2; 1.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF00612; IQ; 2.
DR   Pfam; PF00616; RasGAP; 1.
DR   Pfam; PF03836; RasGAP_C; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00015; IQ; 3.
DR   SMART; SM00323; RasGAP; 1.
DR   SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF143885; RGC domain-like; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS50096; IQ; 3.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calmodulin-binding;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..1575
FT                   /note="Ras GTPase-activating-like protein IQGAP2"
FT                   /id="PRO_0000056650"
FT   DOMAIN          41..156
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          594..627
FT                   /note="WW"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          690..719
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          720..749
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          750..779
FT                   /note="IQ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          917..1150
FT                   /note="Ras-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         356
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         595
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         599
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         716
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         782
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         881
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UQ44"
FT   MOD_RES         1002
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1269
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1279
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         1461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..447
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_010629"
FT   VAR_SEQ         448..453
FT                   /note="QEENDR -> MHSLPG (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_010630"
FT   VAR_SEQ         448..453
FT                   /note="QEENDR -> MGCFKG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055149"
FT   VAR_SEQ         642..698
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_010631"
FT   VARIANT         455
FT                   /note="V -> A (in dbSNP:rs7722711)"
FT                   /id="VAR_055823"
FT   VARIANT         479
FT                   /note="P -> R (in dbSNP:rs3822530)"
FT                   /id="VAR_055824"
FT   VARIANT         527
FT                   /note="D -> E (in dbSNP:rs2431352)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:8756646, ECO:0000269|Ref.2"
FT                   /id="VAR_062958"
FT   VARIANT         532
FT                   /note="K -> E (in dbSNP:rs2909888)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:8756646, ECO:0000269|Ref.2"
FT                   /id="VAR_059292"
FT   VARIANT         629
FT                   /note="L -> F (in dbSNP:rs2455230)"
FT                   /evidence="ECO:0000269|PubMed:8756646, ECO:0000269|Ref.2,
FT                   ECO:0007744|PubMed:21269460"
FT                   /id="VAR_062959"
FT   VARIANT         714
FT                   /note="R -> W (in dbSNP:rs35366349)"
FT                   /id="VAR_055825"
FT   VARIANT         724
FT                   /note="I -> V (in dbSNP:rs2431363)"
FT                   /evidence="ECO:0000269|PubMed:8756646, ECO:0000269|Ref.2"
FT                   /id="VAR_062960"
FT   VARIANT         894
FT                   /note="T -> I (in dbSNP:rs34950321)"
FT                   /id="VAR_055826"
FT   VARIANT         1052
FT                   /note="R -> I (in dbSNP:rs2287932)"
FT                   /id="VAR_055827"
FT   VARIANT         1184
FT                   /note="N -> S (in dbSNP:rs10454915)"
FT                   /id="VAR_055828"
FT   VARIANT         1379
FT                   /note="R -> W (in dbSNP:rs17681908)"
FT                   /id="VAR_055829"
FT   VARIANT         1445
FT                   /note="Y -> C (in dbSNP:rs369078465)"
FT                   /evidence="ECO:0000269|PubMed:23033978"
FT                   /id="VAR_069434"
FT   VARIANT         1530
FT                   /note="M -> I (in dbSNP:rs150409607)"
FT                   /evidence="ECO:0000269|PubMed:23033978"
FT                   /id="VAR_069435"
FT   CONFLICT        95
FT                   /note="V -> E (in Ref. 3; BAF83755)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        778
FT                   /note="N -> S (in Ref. 3; BAF83755)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1101
FT                   /note="G -> R (in Ref. 3; BAF83755)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1333
FT                   /note="V -> L (in Ref. 3; BAH13890)"
FT                   /evidence="ECO:0000305"
FT   HELIX           878..894
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           896..905
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           908..911
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   TURN            912..914
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           915..925
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           929..950
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   STRAND          952..955
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           956..959
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           963..973
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   STRAND          974..977
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           982..994
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1004..1010
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1012..1015
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1016..1018
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1031..1034
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1038..1064
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1065..1068
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1071..1087
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1093..1104
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1105..1109
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1110..1114
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   TURN            1116..1120
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1132..1149
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1159..1164
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1165..1182
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1188..1191
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   TURN            1192..1194
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1195..1198
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   STRAND          1208..1214
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1223..1225
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1226..1229
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   HELIX           1232..1243
FT                   /evidence="ECO:0007829|PDB:5CJP"
FT   STRAND          1479..1482
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   HELIX           1483..1488
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   STRAND          1491..1495
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   HELIX           1500..1505
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   STRAND          1506..1512
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   STRAND          1518..1525
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   STRAND          1528..1536
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   HELIX           1537..1545
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   STRAND          1550..1554
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   STRAND          1557..1560
FT                   /evidence="ECO:0007829|PDB:3IEZ"
FT   HELIX           1561..1569
FT                   /evidence="ECO:0007829|PDB:3IEZ"
SQ   SEQUENCE   1575 AA;  180578 MW;  BCC8CED6645CB09B CRC64;
     MPHEELPSLQ RPRYGSIVDD ERLSAEEMDE RRRQNIAYEY LCHLEEAKRW MEVCLVEELP
     PTTELEEGLR NGVYLAKLAK FFAPKMVSEK KIYDVEQTRY KKSGLHFRHT DNTVQWLRAM
     ESIGLPKIFY PETTDVYDRK NIPRMIYCIH ALSLYLFKLG IAPQIQDLLG KVDFTEEEIS
     NMRKELEKYG IQMPSFSKIG GILANELSVD EAALHAAVIA INEAVEKGIA EQTVVTLRNP
     NAVLTLVDDN LAPEYQKELW DAKKKKEENA RLKNSCISEE ERDAYEELLT QAEIQGNINK
     VNRQAAVDHI NAVIPEGDPE NTLLALKKPE AQLPAVYPFA AAMYQNELFN LQKQNTMNYL
     AHEELLIAVE MLSAVALLNQ ALESNDLVSV QNQLRSPAIG LNNLDKAYVE RYANTLLSVK
     LEVLSQGQDN LSWNEIQNCI DMVNAQIQEE NDRVVAVGYI NEAIDEGNPL RTLETLLLPT
     ANISDVDPAH AQHYQDVLYH AKSQKLGDSE SVSKVLWLDE IQQAVDDANV DKDRAKQWVT
     LVVDVNQCLE GKKSSDILSV LKSSTSNAND IIPECADKYY DALVKAKELK SERVSSDGSW
     LKLNLHKKYD YYYNTDSKES SWVTPESCLY KESWLTGKEI EDIIEEVTVG YIRENIWSAS
     EELLLRFQAT SSGPILREEF EARKSFLHEQ EENVVKIQAF WKGYKQRKEY MHRRQTFIDN
     TDSIVKIQSW FRMATARKSY LSRLQYFRDH NNEIVKIQSL LRANKARDDY KTLVGSENPP
     LTVIRKFVYL LDQSDLDFQE ELEVARLREE VVTKIRANQQ LEKDLNLMDI KIGLLVKNRI
     TLEDVISHSK KLNKKKGGEM EILNNTDNQG IKSLSKERRK TLETYQQLFY LLQTNPLYLA
     KLIFQMPQNK STKFMDTVIF TLYNYASNQR EEYLLLKLFK TALEEEIKSK VDQVQDIVTG
     NPTVIKMVVS FNRGARGQNT LRQLLAPVVK EIIDDKSLII NTNPVEVYKA WVNQLETQTG
     EASKLPYDVT TEQALTYPEV KNKLEASIEN LRRVTDKVLN SIISSLDLLP YGLRYIAKVL
     KNSIHEKFPD ATEDELLKIV GNLLYYRYMN PAIVAPDGFD IIDMTAGGQI NSDQRRNLGS
     VAKVLQHAAS NKLFEGENEH LSSMNNYLSE TYQEFRKYFK EACNVPEPEE KFNMDKYTDL
     VTVSKPVIYI SIEEIISTHS LLLEHQDAIA PEKNDLLSEL LGSLGEVPTV ESFLGEGAVD
     PNDPNKANTL SQLSKTEISL VLTSKYDIED GEAIDSRSLM IKTKKLIIDV IRNQPGNTLT
     EILETPATAQ QEVDHATDMV SRAMIDSRTP EEMKHSQSMI EDAQLPLEQK KRKIQRNLRT
     LEQTGHVSSE NKYQDILNEI AKDIRNQRIY RKLRKAELAK LQQTLNALNK KAAFYEEQIN
     YYDTYIKTCL DNLKRKNTRR SIKLDGKGEP KGAKRAKPVK YTAAKLHEKG VLLDIDDLQT
     NQFKNVTFDI IATEDVGIFD VRSKFLGVEM EKVQLNIQDL LQMQYEGVAV MKMFDKVKVN
     VNLLIYLLNK KFYGK
//
